tiprankstipranks

Vimal Mehta Insider Profile

25 Followers
Vimal Mehta, CEO & President, Director, Ten Percent Owner at Bioxcel Therapeutics, holds 7.74M shares in Bioxcel Therapeutics (Ticker: BTAI).
tipranks
Vimal Mehta

Vimal Mehta
Bioxcel Therapeutics (BTAI)
CEO & President, Director, Ten Percent Owner

Ranked #160 out of 97,944 Corporate Insiders

Profitable Transactions

90%
9 out of 10 Profitable Transactions

Average Return

+121.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
100.00%
A breakdown of Vimal Mehta's holdings

Insider Roles

Bioxcel Therapeutics
(BTAI)
CEO & President, Director, Ten Percent Owner
Roles that Vimal Mehta holds in companies

Most Profitable Insider Trade

Stock:
Bioxcel Therapeutics
(BTAI)
Rating:Informative Buy
Date:Aug 19, 2019 - Aug 19, 2020
Return:+374.00%
The most profitable trade made by Vimal Mehta

Vimal Mehta's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bioxcel Therapeutics
Jun 18, 2024
CEO & President, Director, Ten Percent Owner
Uninformative Buy
8.37K
$8.66M
Success Rate for
BTAI
9 out of 10 profitable transactions on
BTAI
90%
Average Return for
BTAI
Average return per transaction on
BTAI
+121.15%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 16, 2023
Uninformative Buy
$212.18K
-
$20.33
Mar 22, 2023
Uninformative Buy
$24.60K
-
$0.41
Jun 16, 2023
Uninformative Buy
$80.12K
-
$1.27
Sep 18, 2023
Uninformative Buy
$8.90K
-
$3.41
Dec 18, 2023
Uninformative Buy
$8.45K
-
$3.24
List of latest transactions for each holding click on a transaction to see Vimal Mehta's performance on stock

Vimal Mehta insider profile FAQ

What is the percentage of profitable transactions made by Vimal Mehta?
The percentage of profitable transactions made by Vimal Mehta is 90%.
    What is the average return per transaction made by Vimal Mehta?
    The average return per transaction made by Vimal Mehta is 121.10%.
      What stocks does Vimal Mehta hold?
      Vimal Mehta holds: BTAI stocks.
        What was Vimal Mehta’s latest transaction?
        Vimal Mehta latest transaction was an Uninformative Buy of $8.37K.
          What was Vimal Mehta's most profitable transaction?
          Vimal Mehta’s most profitable transaction was an Informative Buy of BTAI stock on August 19, 2019. The return on the trade was 374.00%.
            What is Vimal Mehta's role in Bioxcel Therapeutics?
            Vimal Mehta's role in Bioxcel Therapeutics is CEO & President, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.